CD276 and neoplasm: With respect to pancreatic cancer, high levels of B7-H3 are associated with worse survival outcome (55) and tumor progression (58), with in vitro work pointing to the involvement of B7-H3 in resisting gemcitabine-induced apoptosis in pancreatic cancer cell lines (59, 60).